See more : Captivision Inc. Warrant (CAPTW) Income Statement Analysis – Financial Results
Complete financial analysis of SIGA Technologies, Inc. (SIGA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of SIGA Technologies, Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- Schroder British Opportunities Trust PLC (SBO.L) Income Statement Analysis – Financial Results
- Leon Technology Co., Ltd. (300603.SZ) Income Statement Analysis – Financial Results
- TGI Solar Power Group Inc. (TSPG) Income Statement Analysis – Financial Results
- XTL Biopharmaceuticals Ltd. (XTLB.TA) Income Statement Analysis – Financial Results
- PIERER Mobility AG (PKTM.VI) Income Statement Analysis – Financial Results
SIGA Technologies, Inc. (SIGA)
About SIGA Technologies, Inc.
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla Therapeutics to deliver sustained innovation and access to antibacterial drugs primarily against biothreats. The company was incorporated in 1995 and is headquartered in New York, New York.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 139.92M | 110.78M | 133.67M | 124.96M | 26.74M | 477.05M | 12.27M | 14.99M | 8.18M | 3.14M | 5.52M | 8.97M | 12.73M | 19.22M | 13.81M | 8.07M | 6.70M | 7.26M | 8.48M | 1.84M | 731.74K | 344.45K | 1.16M | 483.12K | 500.00K | 500.00K | 700.00K | 100.00K |
| Cost of Revenue | 17.83M | 32.96M | 26.54M | 25.74M | 15.09M | 108.29M | 16.68M | 19.71M | 13.13M | 10.83M | 13.86M | 18.21M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -945.40K | -400.00K | -200.00K | 0.00 | 0.00 |
| Gross Profit | 122.09M | 77.82M | 107.13M | 99.22M | 11.66M | 368.77M | -4.41M | -4.72M | -4.95M | -7.69M | -8.34M | -9.24M | 12.73M | 19.22M | 13.81M | 8.07M | 6.70M | 7.26M | 8.48M | 1.84M | 731.74K | 344.45K | 1.16M | 1.43M | 900.00K | 700.00K | 700.00K | 100.00K |
| Gross Profit Ratio | 87.26% | 70.25% | 80.14% | 79.40% | 43.59% | 77.30% | -35.95% | -31.51% | -60.60% | -244.93% | -151.06% | -103.02% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 295.69% | 180.00% | 140.00% | 100.00% | 100.00% |
| Research & Development | 16.43M | 24.11M | 9.94M | 10.94M | 13.30M | 13.02M | 16.68M | 19.71M | 13.13M | 10.83M | 13.86M | 18.21M | 18.37M | 22.66M | 17.42M | 11.61M | 9.94M | 9.15M | 8.30M | 4.17M | 2.94M | 1.77M | 1.73M | 2.61M | 1.70M | 2.90M | 900.00K | 700.00K |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 12.88M | 12.30M | 13.71M | 24.99M | 200.99M | 1.42M | 1.88M | 25.74M | 1.15M | 734.17K | 5.19M | 4.22M | 4.92M | 2.71M | 4.44M | 2.95M | 1.94M | 2.57M | 4.96M | 2.30M | 2.80M | 2.00M | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -14.41M | -188.47M | 11.82M | 9.53M | 0.00 | 8.13M | 7.53M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 22.04M | 35.12M | 17.32M | 14.00M | 13.25M | 12.88M | 12.30M | 13.71M | 10.58M | 12.52M | 13.24M | 11.41M | 25.74M | 9.28M | 8.27M | 5.19M | 4.22M | 4.92M | 2.71M | 4.44M | 2.95M | 1.94M | 2.57M | 4.96M | 2.30M | 2.80M | 2.00M | 800.00K |
| Other Expenses | 0.00 | -24.11M | 710.15K | 719.14K | 726.11K | 78.94M | 16.79K | -1.66M | 42.20K | 1.07K | 1.50K | 522.00 | 0.00 | 0.00 | 4.35B | 0.00 | 0.00 | 0.00 | 0.00 | 2.12M | 136.75K | 0.00 | 117.26K | 945.40K | 400.00K | 200.00K | 100.00K | 0.00 |
| Operating Expenses | 22.04M | 35.12M | 18.03M | 14.72M | 13.98M | 13.67M | 13.21M | 14.62M | 11.59M | 13.51M | 14.67M | 13.29M | 44.11M | 31.94M | 25.69M | 16.80M | 14.16M | 14.07M | 11.01M | 10.72M | 6.03M | 3.71M | 4.42M | 8.51M | 4.40M | 5.90M | 3.00M | 1.50M |
| Cost & Expenses | 56.30M | 68.08M | 44.58M | 40.46M | 29.06M | 121.95M | 29.89M | 34.33M | 24.72M | 24.34M | 28.52M | 31.51M | 44.11M | 31.94M | 25.69M | 16.80M | 14.16M | 14.07M | 11.01M | 10.72M | 6.03M | 3.71M | 4.42M | 7.57M | 4.00M | 5.70M | 3.00M | 1.50M |
| Interest Income | 4.16M | 0.00 | 101.17K | 2.48M | 2.82M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 18.26K | 34.06K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 3.02M | 15.77M | 15.48M | 14.76M | 14.06M | 266.73K | 455.81K | 1.21M | 172.99K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 192.68K | 550.46K | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 538.29K | 517.64K | 522.37K | 529.81K | 527.00K | 69.63K | 132.19K | 174.28K | 247.36K | 351.56K | 463.14K | 419.36K | 568.29K | 625.34K | 475.09K | 459.88K | 1.25M | 1.56M | 1.33M | 1.05M | 739.56K | 317.03K | 556.86K | 945.40K | 400.00K | 200.00K | 100.00K | 900.00K |
| EBITDA | 84.16M | 43.22M | 89.62M | 85.03M | 1.03M | 355.17M | -23.44M | -25.45M | -38.48M | -211.13M | -23.13M | -21.78M | -21.87M | -27.57M | -11.40M | -8.28M | -6.21M | -5.25M | -1.20M | -8.32M | -4.56M | -3.05M | -2.70M | -6.14M | -3.08M | -5.00M | -1.80M | -500.00K |
| EBITDA Ratio | 60.15% | 39.48% | 67.12% | 68.47% | 3.84% | 91.00% | -142.43% | -139.01% | -198.83% | -664.03% | -408.36% | -246.53% | -312.41% | 17.57% | -41.01% | -104.33% | -120.00% | -29.85% | -17.10% | -283.50% | -603.84% | -884.91% | -199.45% | -1,238.31% | -620.00% | -740.00% | -314.29% | -500.00% |
| Operating Income | 83.62M | 42.70M | 89.09M | 84.50M | 500.09K | 355.10M | -18.85M | -31.01M | -30.95M | -209.67M | -23.52M | -22.54M | -31.38M | -12.72M | -11.88M | -8.74M | -7.46M | -6.81M | -2.53M | -9.45M | -5.29M | -3.37M | -3.26M | -7.08M | -3.50M | -5.20M | -2.30M | -1.40M |
| Operating Income Ratio | 59.76% | 38.55% | 66.65% | 67.62% | 1.87% | 74.44% | -153.63% | -206.94% | -378.59% | -6,677.64% | -426.07% | -251.21% | -246.60% | -66.21% | -86.01% | -108.32% | -111.41% | -93.84% | -29.87% | -513.72% | -723.60% | -976.95% | -281.31% | -1,466.21% | -700.00% | -1,040.00% | -328.57% | -1,400.00% |
| Total Other Income/Expenses | 4.16M | 1.43M | 218.94K | -10.99M | -7.86M | 56.54M | -19.48M | -8.67M | -8.04M | -2.27M | -1.28M | 632.05K | 8.94M | -37.45M | -5.74M | 137.53K | 1.82M | -3.09M | 244.79K | 74.97K | -136.75K | 0.00 | -392.37K | -155.59K | 0.00 | -1.30M | 0.00 | -900.00K |
| Income Before Tax | 87.78M | 44.13M | 89.31M | 73.51M | -10.18M | 411.64M | -38.33M | -39.68M | -38.99M | -211.93M | -24.80M | -22.37M | -22.44M | -19.40M | -17.62B | -8.60M | -5.64M | -9.90M | -2.29M | -12.06M | -5.43M | 0.00 | -3.65M | -7.24M | 0.00 | -6.50M | 0.00 | -2.30M |
| Income Before Tax Ratio | 62.73% | 39.84% | 66.81% | 58.83% | -38.06% | 86.29% | -312.41% | -264.78% | -476.88% | -6,749.87% | -449.26% | -249.39% | -176.31% | -100.96% | -127,556.62% | -106.62% | -84.17% | -136.39% | -26.99% | -655.72% | -742.29% | 0.00% | -315.15% | -1,498.41% | 0.00% | -1,300.00% | 0.00% | -2,300.00% |
| Income Tax Expense | 19.71M | 10.23M | 19.86M | 17.17M | -2.94M | -10.17M | -2.09M | 13.88K | 461.98K | 53.53M | -7.62M | -7.84M | -36.03M | 15.47M | 5.74M | -137.53K | -1.82M | 3.09M | -244.79K | 493.36K | -18.26K | -34.06K | 467.79K | 706.06K | 100.00K | 1.40M | -100.00K | 0.00 |
| Net Income | 68.07M | 33.90M | 69.45M | 56.34M | -7.24M | 421.81M | -36.24M | -39.70M | -39.45M | -265.46M | -17.18M | -14.53M | 13.59M | -28.20M | -17.62M | -8.60M | -5.64M | -9.90M | -2.29M | -9.37M | -5.28M | -3.33M | -3.73M | -7.79M | -3.60M | -6.60M | -2.20M | -2.30M |
| Net Income Ratio | 48.65% | 30.61% | 51.96% | 45.09% | -27.08% | 88.42% | -295.34% | -264.87% | -482.53% | -8,454.68% | -311.22% | -161.95% | 106.82% | -146.73% | -127.56% | -106.62% | -84.17% | -136.39% | -26.99% | -509.65% | -721.11% | -967.06% | -321.66% | -1,612.35% | -720.00% | -1,320.00% | -314.29% | -2,300.00% |
| EPS | 0.95 | 0.46 | 0.92 | 0.71 | -0.09 | 5.28 | -0.46 | -0.69 | -0.73 | -4.97 | -0.33 | -0.28 | 0.57 | -0.62 | -0.47 | -0.25 | -0.17 | -0.35 | -0.09 | -0.40 | -0.34 | -0.32 | -0.44 | -1.08 | -0.55 | -1.01 | -0.57 | -0.75 |
| EPS Diluted | 0.95 | 0.46 | 0.91 | 0.71 | -0.09 | 5.10 | -0.46 | -0.69 | -0.73 | -4.97 | -0.33 | -0.28 | 0.09 | -0.62 | -0.47 | -0.25 | -0.17 | -0.35 | -0.09 | -0.40 | -0.34 | -0.32 | -0.44 | -1.08 | -0.55 | -1.01 | -0.57 | -0.75 |
| Weighted Avg Shares Out | 71.36M | 72.93M | 75.32M | 79.26M | 81.03M | 79.92M | 78.77M | 57.19M | 53.78M | 53.41M | 52.05M | 51.64M | 50.93M | 45.15M | 37.46M | 34.73M | 33.33M | 28.20M | 24.82M | 23.72M | 15.72M | 10.45M | 8.50M | 7.20M | 6.58M | 6.54M | 3.89M | 3.07M |
| Weighted Avg Shares Out (Dil) | 71.68M | 73.55M | 76.40M | 79.44M | 82.18M | 82.71M | 78.87M | 57.19M | 53.78M | 53.42M | 52.37M | 51.64M | 54.06M | 45.15M | 37.46M | 34.73M | 33.33M | 28.20M | 24.82M | 23.72M | 15.72M | 10.45M | 8.50M | 7.20M | 6.59M | 6.55M | 3.89M | 3.07M |
SIGA Enters into Exclusive License Agreement with Vanderbilt University for Novel Poxvirus Monoclonal Antibodies
NEW YORK, Oct. 22, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company and leader in infectious diseases, today announced that it entered into an agreement with Vanderbilt University to obtain a license to a...
Lost Money on SIGA Technologies, Inc.(SIGA)? Contact Levi & Korsinsky Regarding an Ongoing Investigation
NEW YORK, NY / ACCESSWIRE / October 21, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of SIGA Technologies, Inc. ("SIGA Technologies, Inc.") (NASDAQ:SIGA) concerning possible violations of federal securities laws. On September 25, 2024,...
Why Siga Technologies Inc. (SIGA) Outpaced the Stock Market Today
In the closing of the recent trading day, Siga Technologies Inc. (SIGA) stood at $6.80, denoting a +0.89% change from the preceding trading day.
Lost Money on SIGA Technologies, Inc.(SIGA)? Contact Levi & Korsinsky Regarding an Ongoing Investigation
NEW YORK, NY / ACCESSWIRE / October 16, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of SIGA Technologies, Inc. ("SIGA Technologies, Inc.") (NASDAQ:SIGA) concerning possible violations of federal securities laws. On September 25, 2024,...
SIGA Technologies, Inc. Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details- SIGA
NEW YORK, NY / ACCESSWIRE / October 15, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of SIGA Technologies, Inc. ("SIGA Technologies, Inc.") (NASDAQ:SIGA) concerning possible violations of federal securities laws. On September 25, 2024,...
Lost Money on SIGA Technologies, Inc. (SIGA)? You May Have Been Affected by Fraud - Contact Levi & Korsinsky
NEW YORK, NY / ACCESSWIRE / October 14, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of SIGA Technologies, Inc. ("SIGA Technologies, Inc.") (NASDAQ:SIGA) concerning possible violations of federal securities laws. On September 25, 2024,...
Levi & Korsinsky Reminds Shareholders of an Investigation into SIGA Technologies, Inc. (SIGA) Regarding Potential Securities Fraud Allegations
NEW YORK, NY / ACCESSWIRE / October 11, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of SIGA Technologies, Inc. ("SIGA Technologies, Inc.") (NASDAQ:SIGA) concerning possible violations of federal securities laws. On September 25, 2024,...
Siga Technologies Inc. (SIGA) Increases Despite Market Slip: Here's What You Need to Know
Siga Technologies Inc. (SIGA) closed at $6.60 in the latest trading session, marking a +0.92% move from the prior day.
Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating SIGA Technologies, Inc. for potential violations of federal securities laws
NEW YORK, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP ("Wolf Haldenstein"), a preeminent national shareholder rights litigation firm, announces that it is investigating potential securities claims on behalf of purchasers of SIGA Technologies, Inc.(NASDAQ:...
Lost Money on SIGA Technologies, Inc. (SIGA)? You May Have Been Affected by Fraud - Contact Levi & Korsinsky
NEW YORK, NY / ACCESSWIRE / October 10, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of SIGA Technologies, Inc. ("SIGA Technologies, Inc.") (NASDAQ:SIGA) concerning possible violations of federal securities laws. On September 25, 2024,...
Source: https://incomestatements.info
Category: Stock Reports